JPH01117812A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH01117812A JPH01117812A JP27467987A JP27467987A JPH01117812A JP H01117812 A JPH01117812 A JP H01117812A JP 27467987 A JP27467987 A JP 27467987A JP 27467987 A JP27467987 A JP 27467987A JP H01117812 A JPH01117812 A JP H01117812A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- astringent
- chondroitin sulfate
- cosmetic
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 15
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 14
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 14
- 229910021645 metal ion Inorganic materials 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 10
- 239000006071 cream Substances 0.000 abstract description 9
- 239000003212 astringent agent Substances 0.000 abstract description 7
- -1 foundation Substances 0.000 abstract description 5
- 239000006210 lotion Substances 0.000 abstract description 4
- 239000011701 zinc Substances 0.000 abstract description 4
- 229910052725 zinc Inorganic materials 0.000 abstract description 4
- 229910052782 aluminium Inorganic materials 0.000 abstract description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract description 2
- 150000001455 metallic ions Chemical class 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 208000008454 Hyperhidrosis Diseases 0.000 abstract 1
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000036620 skin dryness Effects 0.000 abstract 1
- 230000035900 sweating Effects 0.000 abstract 1
- 239000008213 purified water Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 229920002567 Chondroitin Polymers 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 6
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 5
- 229960001763 zinc sulfate Drugs 0.000 description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は皮膚化粧料例えばファンデーション、クリーム
、アストリンゼンドロージョンその他の皮膚化粧料に関
するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to skin cosmetics such as foundations, creams, astringent lotions and other skin cosmetics.
[従来の技術]
従来ファンデーション、アストリンゼントなどの皮膚化
粧料において、肌をひきしめるために収れん剤が配合さ
些ていることはよく知られている。このような収れん剤
としては通常、硫酸亜鉛、硫酸アルミニウム、塩化亜鉛
、塩化アルミニウムなどが用いられている。[Prior Art] It is well known that conventional skin cosmetics such as foundations and astringents contain astringents to tighten the skin. As such astringents, zinc sulfate, aluminum sulfate, zinc chloride, aluminum chloride, etc. are usually used.
[発明か解決しようとする問題点コ
しかしながら、上記のような収れん剤は、いずれも作用
か強いため刺激性や多少の腐食性もあるので、炎症を起
す場合があり、肌荒れや肌のかさつきの原因となる問題
点があった。[Problems to be solved by the invention] However, all of the above astringents are highly effective, irritating, and somewhat corrosive, so they may cause inflammation, and they may cause skin roughness or dryness. There was a problem that caused this.
本発明はこのような従来の問題点を解決し、上記のよう
な不都合を起こすことなく、制汗効果をあげ化粧くずれ
のない皮膚化粧料を提供することを目的とするものであ
る。It is an object of the present invention to solve these conventional problems and to provide a skin cosmetic that exhibits an antiperspirant effect and does not leave makeup smudged, without causing the above-mentioned inconveniences.
[問題点を解決するための手段] 本発明においては、適度の収れん作用を有し。[Means for solving problems] In the present invention, it has a moderate astringent effect.
かつ障害となる副作用がなく、シかも皮膚に有効な効果
をあげ得る収れん剤について鋭意研究の結果、収れん性
のある金属イオンをコンドロイチン硫酸イオンと結合さ
せたものを存在させることにより、上記問題点を解決し
たものである。As a result of extensive research into an astringent that can have an effective effect on the skin without any harmful side effects, we found that the above problems can be solved by the presence of an astringent metal ion combined with chondroitin sulfate ion. This is the solution.
すなわち本発明は、コンドロイチン硫酸イオンと、収れ
ん性を有する金属イオンとの結合体を配合したことを特
徴とする皮膚化粧料である。That is, the present invention is a skin cosmetic characterized by containing a combination of chondroitin sulfate ions and metal ions having astringent properties.
[作用〕
コンドロイチン硫酸はムコ多糖類に属する多糖体の硫酸
エステルて、肌に対して保湿効果がありまた消炎作用も
有し皮膚をなめらかにし、キメを整え化粧ののりを良く
する効果を有するものである。そしてそのイオンは1価
はもとより2〜3価金属イオンと結合しても沈澱が生じ
ない数少いポリイオンである。したがって、収れん作用
を有する2価の亜鉛イオンや3価のアルミニウムイオン
と結合しても沈澱を生しることがなく、安定であり前述
した収れん性金属イオンの欠点を補うことがてきる0本
発明においては前記結合体としては、例えばコンドロイ
チン硫酸亜鉛又はコンドロイチン硫酸アルミニウムを用
い、これを化粧水又はクリーム等皮膚化粧料に配合して
含有させることによって目的を達成することができる。[Action] Chondroitin sulfate is a sulfate ester of a polysaccharide that belongs to the mucopolysaccharides, and has a moisturizing effect on the skin, and also has an anti-inflammatory effect, and has the effect of smoothing the skin, adjusting the texture, and improving the adhesion of makeup. It is. This ion is one of the few polyions that does not cause precipitation even when combined with monovalent or divalent or trivalent metal ions. Therefore, even when combined with divalent zinc ions and trivalent aluminum ions, which have an astringent action, they do not form a precipitate, are stable, and can compensate for the drawbacks of the astringent metal ions mentioned above. In the invention, the object can be achieved by using, for example, chondroitin zinc sulfate or chondroitin aluminum sulfate as the conjugate and incorporating it into a skin cosmetic such as a lotion or cream.
配合量としては、化粧品の種類に応じて決定実施され特
に限定されるものてはない示、通常化粧料基剤に対し0
.05〜20.00%の範囲で配合することが好ましい
。The amount to be blended is determined depending on the type of cosmetic product and is not particularly limited.
.. It is preferable to mix it in the range of 05 to 20.00%.
[実施例コ
本発明において化粧料中に存在させるためのコンドロイ
チン硫酸イオンと、収れん性を有する金属イオンとの結
合体の製造例。[Example 2] An example of producing a conjugate of chondroitin sulfate ion and an astringent metal ion to be present in a cosmetic in the present invention.
製造例−1コンドロイチン硫酸亜鉛
20%のコンドロイチン硫酸ナトリウム水溶液100g
に硫酸亜鉛0.2gを混合攪拌する0次にそのものを9
9.5%エタノール中に滴下し。Production example-1 100g of sodium chondroitin sulfate aqueous solution containing 20% zinc chondroitin sulfate
Mix and stir 0.2g of zinc sulfate.
Drop into 9.5% ethanol.
凝集したものを分取し、乾燥する。Separate the aggregated material and dry it.
製造例−2コンドロイチン硫酸アルミニウム20%のコ
ンドロイチン硫酸ナトリウム水溶液100gに硫酸アル
ミニウム0.6gを混合攪拌する0次にそのものを99
.5%エタノール中に滴下し、凝集したものを分取し、
乾燥する。Production Example-2 Mix and stir 0.6 g of aluminum sulfate to 100 g of a 20% sodium chondroitin sulfate aqueous solution.
.. Drop it into 5% ethanol, collect the aggregated material,
dry.
実施例−1ファンデーション(A)(数字はwt%)1
、 ステアリン酸
2.82、 親油型モノステアリン酸グ
リセリン 1.43、 セチ
ルアルコール
0.94、 流動パラフィン
12.95、 ラノリン
2.86、 ミリスチン偕イソプロピル
1.57、 セスキオレイ4ソ
ルビタン 0. 1
8、 パラオキシ安息香酸エステル
0.29.0.1%カルボキシメチルセ
ルロースナトリウム水溶液 41.71O9トリエ
タノールアミン
1.111、 1,3−ブチレングリコール
7・512、 ケイ
酸アルミニウムマグネシウム
0.513、 タルク
1.314、 酸化
チタン
8.615、 顔料
1.716、
コンドロイチン硫酸亜鉛
1.017、 精製水
13.71B、 香料
0.3製法
1〜8を加温溶解し80°Cに保ち、別に9〜15を加
温溶解分散し、85℃に保ったものを加え、攪拌混合し
ながら冷却し、50℃の時、17に16を溶解したもの
及び18を加え更に室温まで攪拌しながら冷却してファ
ンデーション(A)を得た。Example-1 Foundation (A) (numbers are wt%) 1
, stearic acid
2.82, Lipophilic glyceryl monostearate 1.43, Cetyl alcohol
0.94, liquid paraffin
12.95, lanolin
2.86, myristic isopropyl
1.57, sesquiolei-4 sorbitan 0. 1
8. Paraoxybenzoic acid ester
0.29.0.1% carboxymethylcellulose sodium aqueous solution 41.71O9 triethanolamine
1.111, 1,3-butylene glycol
7.512, magnesium aluminum silicate
0.513, talc
1.314, titanium oxide
8.615, pigment
1.716,
chondroitin sulfate zinc
1.017, Purified water
13.71B, fragrance
0.3 Manufacturing method 1 to 8 were dissolved by heating and kept at 80°C, 9 to 15 were separately dissolved and dispersed by heating and kept at 85°C. Added, cooled while stirring and mixing, and when the temperature was 50°C, A solution of 16 and 18 were added to 17, and the mixture was further cooled to room temperature with stirring to obtain a foundation (A).
比較例−(B)
コンドロイチン硫酸亜鉛に代えて硫酸亜鉛を0、・5%
用い、精製水を14.2%とした外は実施例−1と同様
に行なってファンデーション(B)を得た。Comparative example - (B) 0.5% zinc sulfate instead of chondroitin zinc sulfate
Foundation (B) was obtained in the same manner as in Example 1, except that purified water was used at 14.2%.
比較例−(C)
コンドロイチン硫酸を配合せず、精製水を14.7%用
いた外は実施例−1と同様に行なりてファンデーション
(C)を得た。Comparative Example (C) A foundation (C) was obtained in the same manner as in Example 1, except that chondroitin sulfate was not blended and 14.7% of purified water was used.
実施例−2ベースクリーム(D)
1、 ステアリン酸
5.02、 ベヘニルアルコール
0.53、 スク
ワラン
15.04、 モノオレイ4ポリオキシエチレンソル
ビタン 1.05、 テトラオレイ4ポ
リオキシエチレンソルビット 1.56、
自己乳化型モノメチアリ4グリセリン
3.07、 オクタン偕セチル
5.08、 パラオキシ
安息香酸エステル 0
.29.1,3−ブチレングリコール
5・010、 精製水
53.61
1、 コンドロイチン硫酸アルミニウム
1.012、 精製水
9.013
. 香料
0.2製法
1〜8を加温溶解し78℃に保ち、別に9.10を加温
溶解し、80°Cに保ったものを加え攪拌混合しながら
冷却して50℃にて12に11を溶解したもの及び13
を加え更に室温まで攪拌しながら冷却してベースクリー
ム(D)を得た。Example-2 Base cream (D) 1. Stearic acid
5.02, Behenyl alcohol
0.53, squalane
15.04, Monooley 4 polyoxyethylene sorbitan 1.05, Tetraoley 4 polyoxyethylene sorbitan 1.56,
Self-emulsifying monometial 4-glycerin
3.07, Octane Kacetyl
5.08, paraoxybenzoic acid ester 0
.. 29.1,3-butylene glycol
5.010, Purified water
53.61
1. Chondroitin aluminum sulfate
1.012, Purified water
9.013
.. fragrance
0.2 Manufacturing methods 1 to 8 were dissolved by heating and kept at 78°C. Separately, 9.10 was dissolved by heating and kept at 80°C. Cooled while stirring and mixing, and 12 to 11 was prepared at 50°C. and 13
was added and further cooled to room temperature while stirring to obtain a base cream (D).
比較例−(E)
コンドロイチン硫酸アルミニウムに代えて塩化アルミニ
ウム用い、精製水を9.5%とした外は実施例−2と同
様に行ってベースクリーム(E)を得た。Comparative Example (E) A base cream (E) was obtained in the same manner as in Example 2, except that aluminum chloride was used instead of aluminum chondroitin sulfate and purified water was changed to 9.5%.
比較例−(F) コンドロイチン硫酸アルミニウムを配合せず。Comparative example-(F) Contains no chondroitin aluminum sulfate.
精製水を10.0%用いた外は実施例−2と同様に行な
ってベースクリーム(F)を得た。A base cream (F) was obtained in the same manner as in Example 2, except that 10.0% purified water was used.
実施例−3アストリンゼンドロージョン1、 ポリオキ
シエチレン硬化ヒマシ油
0.62、 香料
0. 13、 エタノール
1
5.04、 パラオキシ安息香酸エステル
0.15、 精製水
79.76、
コンドロイチン硫酸亜鉛
0.57.1.3−ブチレンゲリコール
4.0製法
l、2.4を3に溶解したものを、別に5に6.7を溶
解したものを混合攪拌して均一にして製する。Example-3 Astringent Lotion 1, Polyoxyethylene hydrogenated castor oil
0.62, fragrance
0. 13. Ethanol
1
5.04 Paraoxybenzoic acid ester
0.15, purified water
79.76,
chondroitin sulfate zinc
0.57.1.3-Butylene gelicol
4.0 Preparation method 1, 2.4 dissolved in 3, and 6.7 dissolved in 5 are mixed and stirred to produce a uniform product.
実施例−4デオドラントクリーム
1、 ステアリA
4.02、 セチルアルコール
2.03、 親油型モ
ノステアリン駿グリセリン 1
0.04、 ミリスチ涜イソプロピル
4.05、 イソプロピルメチ
ルフェノール 0.56
.1,3−ブチレングリコール
12.07、 カセイカリ
1.08、 精製水
5
6.09、 コンドロイチン硫酸アルミニウム
1.010、 精製水
9.0
11、 香料
0・5製法
1〜5を加温溶解して75℃に保ち、別に6〜8を加温
溶解し75°Cに保ったものを加え、攪拌混合しながら
冷却して50℃にて、lOに9を溶解したもの及び11
を加え更に攪拌しながら冷却してデオトラントクリーム
を得た。Example-4 Deodorant cream 1, Steari A
4.02, Cetyl alcohol
2.03, Lipophilic monostearin glycerin 1
0.04, myristic isopropyl
4.05, Isopropylmethylphenol 0.56
.. 1,3-butylene glycol
12.07, Caustic Cali
1.08, Purified water 5
6.09, chondroitin aluminum sulfate
1.010, Purified water
9.0
11. Fragrance
0.5 Preparation method 1 to 5 were heated and dissolved and kept at 75°C. Separately, 6 to 8 were heated and dissolved and kept at 75°C. Cooled while stirring and mixing, and dissolved at 50°C. 9 dissolved in and 11
was added and further cooled while stirring to obtain a deotrant cream.
製品使用テスト結果 実施例(A、D)及び比較例(B、C,E。Product usage test results Examples (A, D) and comparative examples (B, C, E.
F)について実際10名の女性に使用テストを行い、メ
ーキャップ料の肌へののり、化粧くずれ、刺激感、しっ
とり感について、下記のような基準において評価した。Regarding F), a usage test was conducted on 10 women, and evaluation was made on the adhesion of the makeup composition to the skin, makeup smearing, irritation, and moist feeling based on the following criteria.
但し、D、E、Fについては、化粧下地として使用し、
上から既存のケーキファンデーションを使用した。However, D, E, and F are used as makeup bases.
I used the existing cake foundation from above.
結果は法衣に示すとおりであった。The results were as shown on the robe.
評価基準:
l−悪い 2−少し悪い 3−″fI通4−よい
5−非常によい
BCDEF
メーキャップ料の肌へののり 423523化粧〈
ずれ 542542刺激感
424423しっとり感
5234 ・23[発明の効果]
以上の結果からも明らかなとおり、本発明によれば、収
れん性に伴なう制汗作用が発現され化粧くずれが防がれ
ると共に、従来の収れん剤のような肌荒れや、肌のかさ
つきが防止され、皮膚への保水性がよく、皮膚をしっと
りとなめらかに保つことかでき・るので、皮膚化粧料と
しての効果は大きいものである。Evaluation criteria: l-poor 2-slightly bad 3-″fI 4-good
5-Very good BCDEF makeup on the skin 423523 makeup
Misalignment 542542 Irritation
424423 Moist feeling
5234 ・23 [Effects of the Invention] As is clear from the above results, according to the present invention, the antiperspirant effect associated with astringency is expressed, and makeup deterioration is prevented, and the antiperspirant effect is prevented like that of conventional astringents. It is highly effective as a skin cosmetic because it prevents skin roughness and dryness, has good water retention properties, and keeps the skin moist and smooth.
特許出願人 株式会社セブン化学Patent applicant: Seven Chemical Co., Ltd.
Claims (1)
ンとの結合体を含有させたことを特徴とする皮膚化粧料A skin cosmetic containing a combination of chondroitin sulfate ion and an astringent metal ion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27467987A JPH01117812A (en) | 1987-10-31 | 1987-10-31 | Skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27467987A JPH01117812A (en) | 1987-10-31 | 1987-10-31 | Skin cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01117812A true JPH01117812A (en) | 1989-05-10 |
JPH0156043B2 JPH0156043B2 (en) | 1989-11-28 |
Family
ID=17545053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27467987A Granted JPH01117812A (en) | 1987-10-31 | 1987-10-31 | Skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01117812A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000034211A (en) * | 1998-07-17 | 2000-02-02 | L'oreal Sa | Cosmetic composition containing pigment and antipersirant, and use of the composition |
JP2008126376A (en) * | 2006-11-22 | 2008-06-05 | Mitsubishi Electric Corp | Dust collector for machine tool |
JP2012072088A (en) * | 2010-09-29 | 2012-04-12 | Kao Corp | Bathing agent composition |
-
1987
- 1987-10-31 JP JP27467987A patent/JPH01117812A/en active Granted
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000034211A (en) * | 1998-07-17 | 2000-02-02 | L'oreal Sa | Cosmetic composition containing pigment and antipersirant, and use of the composition |
JP2008126376A (en) * | 2006-11-22 | 2008-06-05 | Mitsubishi Electric Corp | Dust collector for machine tool |
JP2012072088A (en) * | 2010-09-29 | 2012-04-12 | Kao Corp | Bathing agent composition |
Also Published As
Publication number | Publication date |
---|---|
JPH0156043B2 (en) | 1989-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63192703A (en) | External agent for skin | |
WO1997002803A1 (en) | External skin preparation | |
JP4214611B2 (en) | Inorganic pigment composition | |
JPS59219209A (en) | Skin cosmetic | |
JPH101413A (en) | Cosmetic | |
JPS62215510A (en) | Emulsified composition | |
JPH11255638A (en) | Tyrosinase activity inhibitor and cosmetic | |
JPH01117812A (en) | Skin cosmetic | |
JPH0618768B2 (en) | Solid powder cosmetics | |
JPS60116618A (en) | Cosmetic | |
JP2911479B2 (en) | Emulsion composition | |
JP2000169339A (en) | Cosmetic having beautifully whitening effect | |
JPH05301812A (en) | Skin external preparation | |
JP3503879B2 (en) | Cosmetics | |
JP2000204019A (en) | Makeup cosmetic having bleaching effect | |
US20030152599A1 (en) | Composition for external use | |
JP2002012512A (en) | Composition for external use | |
JPS63208505A (en) | Cosmetic | |
JPH1017431A (en) | Skin ununiformity improver and cosmetic containing the same | |
JP2739246B2 (en) | External composition | |
JPS60116616A (en) | Cosmetic | |
JP3664903B2 (en) | Hydroxycarboxylic acid zinc salt | |
JPH09295917A (en) | Stratified type makeup cosmetic | |
JP3604232B2 (en) | Process for producing cosmetic cream and emulsion containing no surfactant | |
JP2791179B2 (en) | Powder cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |